Reynolds Capital Management’s Idexx Laboratories IDXX Stock Holding History

Reynolds Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,500	Closed	-$328K	–	131
2015 Q4	$328K	Sell	4,500 -3,500	-44%	-$250K	0.36%	88
2015 Q3	$594K	Buy	8,000 +1,000	+14%	+$71.6K	0.74%	38
2015 Q2	$449K	Buy	7,000 +2,000	+40%	+$138K	0.44%	73
2015 Q1	$386K	Hold	5,000	–	–	0.34%	100
2014 Q4	$371K	Buy	+5,000	New	+$351K	0.31%	123

Other funds holding IDXX

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Reynolds Capital Management's IDXX Position: Q1 2016 in Review

Reynolds Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2016, closing a stake of 4,500 shares — an estimated $328K sold.

Reynolds Capital Management first reported a position in IDXX in Q4 2014 and held it in 5 quarters. The position peaked at $594K in Q3 2015. 377 funds tracked by Wall St. Rank hold IDXX as of Q1 2016.

Reynolds Capital Management reported no remaining Idexx Laboratories position as of Q1 2016 after selling out during the quarter.
Reynolds Capital Management sold 4,500 Idexx Laboratories shares in Q1 2016, an estimated $328K.
Reynolds Capital Management first reported a position in Idexx Laboratories in Q4 2014 and held it in 5 quarters.
Reynolds Capital Management's Idexx Laboratories position peaked at $594K in Q3 2015.
377 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.